查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1968538

犬类整形外科市场－全球产业规模、份额、趋势、机会和预测：按产品、应用、最终用途、地区和竞争对手划分，2021-2031年

Canine Orthopedics Market- Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Product, By Application, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球犬类整形外科市场预计将从 2025 年的 2.6253 亿美元成长到 2031 年的 4.3474 亿美元，复合年增长率达到 8.77%。

此领域涵盖专门用于治疗犬类肌肉骨骼损伤和退化性疾病的医疗植入、器械和辅助设备的製造和供应。推动该行业发展的主要动力是宠物日益人性化，以及宠物饲养率的不断上升，这促使饲主寻求针对骨关节炎和十字韧带断裂等疾病的先进医疗服务。为了满足不断增长的患者群体，美国兽医协会 (AVMA) 预计，到 2024 年，美国犬隻数量将达到 8,970 万隻，这一数字直接推动了对专业兽医整形外科产品和服务的需求。

市场概览
预测期 2027-2031
市场规模：2025年 2.6253亿美元
市场规模：2031年 4.3474亿美元
复合年增长率：2026-2031年 8.77%
成长最快的细分市场 植入
最大的市场 北美洲

儘管有这些正面趋势，但市场仍存在一个主要障碍：复杂整形外科手术的高昂费用。全髋关节置换术和骨折修復等手术需要昂贵的材料和高技能兽医专家的知识，这对宠物饲主来说是一笔不小的经济负担。这种经济障碍往往限制了未投保宠物获得高品质兽医服务的机会，并阻碍了市场在可支配收入低、兽医基础设施落后的发展中地区的渗透。

市场驱动因素

犬类肌肉骨骼疾病和肥胖症的日益普遍是推动市场扩张的主要动力，也因此对整形外科干预措施的需求持续增长。犬类体重过重会显着加速关节劣化，增加骨关节炎和十字韧带损伤的发生率，这些疾病需要透过手术修復或植入进行长期治疗。体重与整形外科健康之间的关联在临床统计数据中日益凸显。根据宠物肥胖预防协会于2025年4月发布的《2024年宠物肥胖与营养意见调查》，35%的犬饲主认为他们的宠物超重或肥胖，较前一年的17%显着上升。随着高风险犬群的不断扩大，兽医在应对与体重相关的併发症所带来的身体影响时，对从诊断工具到先进手术植入等综合整形外科解决方案的需求也日益增长。

同时，宠物健康保险投保率的不断提高，减轻了昂贵的整形外科手术带来的经济负担，并扩大了高品质医疗服务的覆盖范围。随着保险覆盖范围的扩大，饲主越来越愿意核准诸如全髋关节置换术和骨折修復等昂贵的治疗，而这些治疗费用在他们看来可能难以负担。根据北美宠物健康保险协会（NAPHIA）于2025年4月发布的《2025年产业趋势报告》，截至2024年底，美国宠物保险保费总收入约47亿美元。在兽医费用持续上涨的背景下，这层财务保障至关重要。 Synchrony公司2025年的预测显示，一隻狗的终身医疗费用将从22,125美元增加到60,602美元，而保险业在将潜在需求转化为实际手术收入方面发挥着至关重要的作用。

市场挑战

复杂整形外科手术的高昂费用是全球犬类整形外科市场发展的主要障碍。诸如全髋关节置换术和十字韧带修復等手术需要昂贵的医疗植入和专业兽医外科医生的精湛技艺。因此，这些手术的费用超出了许多宠物饲主的可支配收入，迫使他们选择保守治疗或非手术治疗。在极端情况下，甚至会选择安乐死。这种经济限制直接减少了植入和器械的使用，阻碍了市场的获利能力，并限制了先进技术的推广应用。

此外，由于宠物健康保险普及率仍然很低，市场严重依赖自费支付。缺乏经济保障加剧了饲主在获得可负担医疗服务方面的不平等，尤其是在面临意外高额医疗费用时。根据北美宠物健康保险协会（NAPHIA）的数据，到2024年，北美地区投保宠物的总数将达到703万隻。这项数据表明，绝大多数宠物仍然没有保险，迫使大多数饲主独自承担高昂的整形外科治疗费用，并极大地限制了外科手术治疗方案的潜在市场。

市场趋势

再生医学与整形外科手术的融合正将市场重心从简单的症状管理转向生物修復。兽医外科医生越来越多地将干细胞疗法和富血小板血浆（PRP）疗法与外科手术相结合，以促进组织癒合并延缓骨关节炎的进展。随着生技公司吸引大量投资用于开发标准化、即用型生物製品，这种方法正逐渐具备商业性可行性。例如，在2025年6月题为「Gallant完成1800万美元B轮资金筹措，将推出可上市的宠物干细胞疗法」的新闻稿中，Gallant宣布已获得1800万美元资金，用于推进其同种异体干细胞产品线获得FDA有条件核准。这表明，治疗方向正从单纯掩盖疼痛转向能够治疗关节退化根本原因的可扩展治疗方法。

同时，专业的术后復健技术的推广应用，正将结构化的復健通讯协定确立为整形外科治疗的关键要素。兽医界普遍认为，专业的復健治疗能显着改善手术效果，因此对运动医学专家和特定復健计画的需求日益增长。此外，用于完善竞技犬復健技术的临床研究经费的增加也进一步推动了这项进展。根据美国犬业俱乐部犬类健康基金会于2025年8月发布的《2024年影响报告》，该基金会策略性地投资了320万美元，用于42项研究津贴，其中包括对运动医学和復健专家培训计画的专项支持。这项工作对于检验实证策略至重要，能够确保复杂的整形外科修復手术能带来最佳的长期功能活动能力。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球犬类整形外科市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 副产品（植入、器械）
    • 依应用领域（TPLO、TTA、关节重建、创伤、其他）
    • 依最终用途（医院/诊所、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美犬类整形外科市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲犬类整形外科市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区犬类整形外科市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲犬类整形外科市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美犬类整形外科市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球犬类整形外科市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • B. Braun SE
  • Movora
  • Steris Plc
  • Johnson & Johnson Services, Inc.
  • Cencora, Inc.
  • Arthrex, Inc.
  • Orthomed（UK）Ltd
  • Veterinary Instrumentation Ltd
  • Fusion Implants
  • Narang Medical Limited

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 23986

The Global Canine Orthopedics Market is projected to expand from USD 262.53 Million in 2025 to USD 434.74 Million by 2031, achieving a compound annual growth rate (CAGR) of 8.77%. This sector encompasses the production and supply of medical implants, instruments, and supportive devices specifically engineered to manage musculoskeletal injuries and degenerative diseases in dogs. A major force propelling this industry is the growing trend of pet humanization alongside increasing pet ownership, which encourages owners to pursue sophisticated medical treatments for conditions like osteoarthritis and cruciate ligament ruptures. Highlighting this expanding patient base, the American Veterinary Medical Association estimated the United States dog population at 89.7 million in 2024, a figure that directly underpins the demand for specialized veterinary orthopedic products and services.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 262.53 Million
Market Size 2031USD 434.74 Million
CAGR 2026-20318.77%
Fastest Growing SegmentImplants
Largest MarketNorth America

Despite these favorable trends, the market faces a substantial obstacle regarding the significant expense of complex orthopedic surgeries. Procedures such as total hip replacements and fracture repairs necessitate costly materials and the expertise of highly skilled veterinary specialists, creating a heavy financial load for pet owners. This affordability barrier frequently restricts access to premium veterinary care for uninsured pets and hampers market penetration in developing areas where disposable income is lower and veterinary healthcare infrastructure is not yet fully established.

Market Driver

The escalating prevalence of canine musculoskeletal disorders and obesity serves as a primary engine for market expansion, generating consistent demand for orthopedic interventions. Excess body weight in dogs markedly hastens joint deterioration, resulting in higher rates of osteoarthritis and cruciate ligament injuries that necessitate surgical repair or long-term management via implants. The correlation between weight and orthopedic health is increasingly apparent in clinical statistics; according to the Association for Pet Obesity Prevention's '2024 Pet Obesity & Nutrition Opinion Survey' released in April 2025, 35% of dog owners identified their pets as overweight or having obesity, a significant rise from 17% the previous year. This increase in the at-risk population drives the need for comprehensive orthopedic solutions, ranging from diagnostic tools to advanced surgical implants, as veterinarians manage the physical consequences of weight-related comorbidities.

In parallel, the growing uptake of pet health insurance policies is alleviating the financial hurdles linked to expensive orthopedic procedures, thereby widening patient access to high-quality care. As coverage becomes more prevalent, owners are more inclined to authorize costly treatments like total hip replacements or fracture repairs that might otherwise be financially out of reach. According to the North American Pet Health Insurance Association's '2025 State of the Industry Report' from April 2025, total pet insurance premium volume in the United States hit roughly $4.7 billion by the end of 2024. This financial safety net is crucial given the escalating costs of veterinary medicine, with Synchrony estimating in 2025 that the lifetime cost of dog care has increased to between $22,125 and $60,602, making the insurance sector a key facilitator in converting potential demand into realized surgical revenue.

Market Challenge

The significant expense attached to complex orthopedic surgeries acts as a major impediment to the growth of the Global Canine Orthopedics Market. Interventions such as total hip replacements and cruciate ligament repairs require high-cost medical-grade implants and the skills of specialized veterinary surgeons. As a result, the cost of these procedures frequently surpasses the disposable income of many pet owners, compelling them to choose conservative, non-surgical management or, in extreme situations, economic euthanasia. This economic limitation directly decreases the volume of implants and instruments used, thereby hindering market revenue potential and restricting the uptake of advanced technologies.

Additionally, the market depends heavily on out-of-pocket payments because pet health insurance remains relatively uncommon. The absence of financial safety nets worsens the affordability gap, especially when owners confront sudden, substantial medical bills. According to the North American Pet Health Insurance Association, the total number of insured pets in North America reached 7.03 million in 2024. This statistic suggests that the vast majority of the pet population is still uninsured, leaving most owners solely accountable for the heavy financial load of premium orthopedic care and significantly limiting the addressable market for surgical solutions.

Market Trends

The integration of Regenerative Medicine Therapies with Orthopedic Procedures is transitioning the market's focus from simple symptom management to biological restoration. Veterinary surgeons are increasingly combining stem cell therapies and platelet-rich plasma with surgical interventions to hasten tissue healing and slow the progression of osteoarthritis. This method is becoming commercially viable as biotechnology companies attract significant investment to create standardized, off-the-shelf biological products. For instance, Gallant Therapeutics announced in a June 2025 press release, 'Gallant Closes $18 Million Series B to Bring Ready-to-Use Stem Cell Therapies for Pets to Market,' that it secured $18 million to further the conditional FDA approval of its allogeneic stem cell pipeline, signaling a shift toward scalable therapeutics that treat the root causes of joint degeneration rather than just masking pain.

Concurrently, the expansion of Specialized Post-Operative Physical Rehabilitation Modalities is solidifying structured recovery protocols as a vital element of orthopedic care. The veterinary community increasingly acknowledges that surgical results are vastly improved when accompanied by professional rehabilitation, fueling demand for sports medicine specialists and specific recovery programs. This development is bolstered by growing funding for clinical research aimed at perfecting rehabilitation techniques for canine athletes. As reported by the American Kennel Club Canine Health Foundation in its August 2025 '2024 Impact Report,' the organization strategically invested $3.2 million across 42 research grants, including specific support for sports medicine and rehabilitation residency programs, which is essential for validating evidence-based strategies to ensure complex orthopedic repairs lead to optimal long-term functional mobility.

Key Market Players

  • B. Braun SE
  • Movora
  • Steris Plc
  • Johnson & Johnson Services, Inc.
  • Cencora, Inc.
  • Arthrex, Inc.
  • Orthomed (UK) Ltd
  • Veterinary Instrumentation Ltd
  • Fusion Implants
  • Narang Medical Limited

Report Scope

In this report, the Global Canine Orthopedics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Canine Orthopedics Market, By Product

  • Implants
  • Instruments

Canine Orthopedics Market, By Application

  • TPLO
  • TTA
  • Joint Replacement
  • Trauma
  • Others

Canine Orthopedics Market, By End-use

  • Hospitals & Clinics
  • Others

Canine Orthopedics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Canine Orthopedics Market.

Available Customizations:

Global Canine Orthopedics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Canine Orthopedics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Implants, Instruments)
    • 5.2.2. By Application (TPLO, TTA, Joint Replacement, Trauma, Others)
    • 5.2.3. By End-use (Hospitals & Clinics, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Canine Orthopedics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End-use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Canine Orthopedics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Canine Orthopedics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Canine Orthopedics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-use

7. Europe Canine Orthopedics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End-use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Canine Orthopedics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-use
    • 7.3.2. France Canine Orthopedics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-use
    • 7.3.3. United Kingdom Canine Orthopedics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Canine Orthopedics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Canine Orthopedics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-use

8. Asia Pacific Canine Orthopedics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End-use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Canine Orthopedics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Canine Orthopedics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Canine Orthopedics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Canine Orthopedics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Canine Orthopedics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-use

9. Middle East & Africa Canine Orthopedics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End-use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Canine Orthopedics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-use
    • 9.3.2. UAE Canine Orthopedics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-use
    • 9.3.3. South Africa Canine Orthopedics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-use

10. South America Canine Orthopedics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End-use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Canine Orthopedics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-use
    • 10.3.2. Colombia Canine Orthopedics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-use
    • 10.3.3. Argentina Canine Orthopedics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Canine Orthopedics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. B. Braun SE
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Movora
  • 15.3. Steris Plc
  • 15.4. Johnson & Johnson Services, Inc.
  • 15.5. Cencora, Inc.
  • 15.6. Arthrex, Inc.
  • 15.7. Orthomed (UK) Ltd
  • 15.8. Veterinary Instrumentation Ltd
  • 15.9. Fusion Implants
  • 15.10. Narang Medical Limited

16. Strategic Recommendations

17. About Us & Disclaimer